Case Study

Manufacturing Automation Solutions For Allogeneic Cell Therapy Production

Source: Invetech
Intelligent Automation AI

Breakthrough manufacturing automation paves the way for treatment of debilitating illness

One of our clients is working on the development of an allogeneic cell therapy to treat a disease that is increasing in prevalence in both emerging and mature economies alike. The therapy is derived from human umbilical tissue-derived cells (hUTCs) which are harvested then expanded to form a Master Cell Bank of cells. It is these cells that are processed to form the final drug product.

Our role in this ground-breaking development has been to design and supply the automation equipment that produces the cellular drug product for the Phase II and Phase IIb trials. Three equipment platforms have been developed for our client to enable ongoing development for Phase III trials, and ultimately cGMP manufacture commercial product.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: